IS7290A - Pharmaceutical formulations containing risperidone - Google Patents

Pharmaceutical formulations containing risperidone

Info

Publication number
IS7290A
IS7290A IS7290A IS7290A IS7290A IS 7290 A IS7290 A IS 7290A IS 7290 A IS7290 A IS 7290A IS 7290 A IS7290 A IS 7290A IS 7290 A IS7290 A IS 7290A
Authority
IS
Iceland
Prior art keywords
pharmaceutical formulations
formulations containing
containing risperidone
risperidone
pharmaceutical
Prior art date
Application number
IS7290A
Other languages
Icelandic (is)
Inventor
Irnason Birkir
Original Assignee
Actavis Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group filed Critical Actavis Group
Priority to IS7290A priority Critical patent/IS7290A/en
Priority to PCT/IS2005/000014 priority patent/WO2005115346A2/en
Publication of IS7290A publication Critical patent/IS7290A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS7290A 2004-05-28 2004-05-28 Pharmaceutical formulations containing risperidone IS7290A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IS7290A IS7290A (en) 2004-05-28 2004-05-28 Pharmaceutical formulations containing risperidone
PCT/IS2005/000014 WO2005115346A2 (en) 2004-05-28 2005-05-30 Pharmaceutical composition containing risperidone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS7290A IS7290A (en) 2004-05-28 2004-05-28 Pharmaceutical formulations containing risperidone

Publications (1)

Publication Number Publication Date
IS7290A true IS7290A (en) 2005-11-29

Family

ID=36715412

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7290A IS7290A (en) 2004-05-28 2004-05-28 Pharmaceutical formulations containing risperidone

Country Status (2)

Country Link
IS (1) IS7290A (en)
WO (1) WO2005115346A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
EP2152315B1 (en) 2007-05-25 2016-01-06 Indivior UK Limited Sustained delivery formulations of risperidone compounds
WO2009026621A1 (en) * 2007-08-29 2009-03-05 Alphapharm Pty Ltd Pharmaceutical compound & composition
WO2010044097A2 (en) * 2008-09-15 2010-04-22 Intas Pharmaceuticals Limited Novel dosage form of paliperidone and process for preparing the same
CN103356501B (en) * 2012-04-06 2017-08-01 石药集团中奇制药技术（石家庄）有限公司 A kind of Risperidone in Tablets and preparation method thereof
CN105163719B (en) 2013-03-11 2019-03-08 度瑞公司 Injectable control release composition comprising high viscosity liquid carrier
US20140308352A1 (en) 2013-03-11 2014-10-16 Zogenix Inc. Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193386A1 (en) * 2002-03-28 2002-12-19 Inigo Pfeiffer Polymorphic form of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-alpha]pyrimidin-4-one and formulations thereof
ES2199061B1 (en) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. TROUBLE-BASED TABLETS AND PROCEDURE FOR OBTAINING.
AU2003256006A1 (en) * 2002-08-30 2004-03-19 Sunil Sadanand Nadkarni Improved process for preparation of risperidone

Also Published As

Publication number Publication date
WO2005115346A9 (en) 2006-05-18
WO2005115346A2 (en) 2005-12-08
WO2005115346A3 (en) 2006-07-06

Similar Documents

Publication Publication Date Title
IL177566A0 (en) Pharmaceutical formulations
ITBO20050123A1 (en) GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
GB0426301D0 (en) Pharmaceutical formulations
NO20075628L (en) Pharmaceutical formulations
BRPI0511900A (en) pharmaceutical compositions
DK1750683T3 (en) Prolonged-release formulations
IL185390A (en) Solid pharmaceutical dosage formulation
EP1981547A4 (en) Stable therapeutic formulations
GB0409703D0 (en) Pharmaceutical compositions
GB0408308D0 (en) Pharmaceutical compositions
IL180031A0 (en) Stable pharmaceutical formulations of benzimidazole compounds
EP1805154A4 (en) Pharmaceutical compositions
GB0416397D0 (en) Pharmaceutical formulations
GB0423800D0 (en) New pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
IS7290A (en) Pharmaceutical formulations containing risperidone
GB0406048D0 (en) Drug formulations
DE602005005033D1 (en) SPRAY-DRIED PHARMACEUTICAL COMPOSITIONS
ITMI20041447A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING GABAPENTINA
ITMI20040943A1 (en) PHARMACEUTICAL COMPOSITION CICATRIZZANTE
IL182792A0 (en) Pharmaceutical compositions containing gepirone
EP1747205A4 (en) Pharmaceutical compositions
GB0502792D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions
GB0407351D0 (en) Pharmaceutical compositions